Andrew Satlin
Keine laufenden Positionen mehr
Profil
Andrew Satlin worked as the Director of Geriatric Psychiatry at McLean Hospital, Inc. from 1980 to 1997.
He then worked as the EVP & Global Head of Medicine Creation Strategy at Eisai, Inc. from 2008 to 2017.
After that, he served as the Chief Medical Officer & Executive Vice President at Intra-Cellular Therapies, Inc. from 2017 to 2020.
Prior to his work in the industry, he was an Assistant Professor at Harvard Medical School.
Satlin received his undergraduate degree from Yale University and his doctorate from Harvard Medical School.
Ehemalige bekannte Positionen von Andrew Satlin
| Unternehmen | Position | Ende |
|---|---|---|
| INTRA-CELLULAR THERAPIES, INC. | Chief Tech/Sci/R&D Officer | 28.10.2020 |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Corporate Officer/Principal | 01.11.2017 |
McLean Hospital, Inc.
 McLean Hospital, Inc. Hospital/Nursing ManagementHealth Services McLean Hospital, Inc. provides healthcare services. It offers specialized programs for the research and treatment of psychiatric and neurological illnesses, including: depression, bipolar and psychotic disorders, mood and anxiety disorders, substance abuse, geriatric mental illnesses and child adolescent psychiatric disorders. The company was founded in February, 1811 and is headquartered in Belmont, MA. | Corporate Officer/Principal | 01.01.1997 |
| Harvard Medical School | Corporate Officer/Principal | - |
Ausbildung von Andrew Satlin
| Yale University | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INTRA-CELLULAR THERAPIES, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Health Technology |
McLean Hospital, Inc.
McLean Hospital, Inc. Hospital/Nursing ManagementHealth Services McLean Hospital, Inc. provides healthcare services. It offers specialized programs for the research and treatment of psychiatric and neurological illnesses, including: depression, bipolar and psychotic disorders, mood and anxiety disorders, substance abuse, geriatric mental illnesses and child adolescent psychiatric disorders. The company was founded in February, 1811 and is headquartered in Belmont, MA. | Health Services |
